Filing Details
- Accession Number:
- 0001213900-21-011174
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-23 17:34:52
- Reporting Period:
- 2021-02-19
- Accepted Time:
- 2021-02-23 17:34:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1822711 | Fs Development Corp. Ii | FSII | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1581754 | B. James Tananbaum | C/O Fs Development Corp. Ii 600 Montgomery Street, Suite 4500 San Francisco CA 94115 | President & Ceo | Yes | Yes | Yes | No |
1792204 | Foresite Capital Fund V, L.p. | C/O Fs Development Corp. Ii 600 Montgomery Street, Suite 4500 San Francisco CA 94111 | No | No | Yes | No | |
1792206 | Foresite Capital Management V, Llc | C/O Fs Development Corp. Ii 600 Montgomery Street, Suite 4500 San Francisco CA 94111 | No | No | Yes | No | |
1822712 | Fs Development Holdings Ii, Llc | C/O Fs Development Corp. Ii 600 Montgomery Street, Suite 4500 San Francisco CA 94111 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2021-02-19 | 602,500 | $10.00 | 602,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The reported shares of Class A common stock were purchased in a private placement by FS Development Holdings II, LLC (the "Sponsor") for $10.00 per share, as described under the heading "Description of Shares" in the Issuer's registration statement on Form S-1 (File No. 333-252435).
- The Sponsor is the record holder of the shares reported herein. Foresite Capital Fund V, L.P. ("Fund V"), its general partner Foresite Capital Management V, LLC ("FCM V"), and Dr. James Tananbaum, the managing member of FCM V, have voting and investment discretion with respect to the common stock held of record by the Sponsor. Each of Fund V, FCM V, their respective members and Dr. Tananbaum disclaim beneficial ownership of these shares except to the extent of any pecuniary interest therein.